GlassScriptPhysician profile
Monica J Munoz
NPI 1033347117
$14,450.92
in general payments reported to CMS, 2019-2025
37 companies · $1,483 in 2025
The $1,483 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,936 · 2020: $2,776 · 2021: $2,199 · 2022: $1,996 · 2023: $1,907 · 2024: $1,154 · 2025: $1,483.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,479 · Education: $64.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,479.31 |
| Education | $64.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $3,689.36 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,457.59 | 2019-2024 | Farxiga, Lokelma |
| Amgen INC. | $1,397.02 | 2019-2025 | Evenity, Prolia, Tepezza |
| Sanofi-Aventis U.S. LLC | $1,173.78 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $874.92 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Medtronic, INC. | $867.16 | 2021-2025 | Minimed 780g |
| Lilly USA, LLC | $748.92 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Mannkind Corporation | $526.78 | 2019-2023 | Afrezza |
| Abbvie INC. | $375.73 | 2019-2023 | |
| Amarin Pharma, INC. | $362.11 | 2019-2021 | |
| Tandem Diabetes Care, INC. | $361.71 | 2019-2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Insulet Corporation | $325.18 | 2021-2025 | Omnipod |
| Radius Health, INC. | $239.11 | 2020-2025 | Tymlos |
| Corcept Therapeutics | $235.90 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $202.25 | 2021-2023 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Minimed, INC. | $182.82 | 2019-2020 | |
| Abbott Laboratories | $169.04 | 2019-2025 | Freestyle Libre 3 |
| Sequel Med Tech, LLC | $144.41 | 2025 | Twiist |
| Janssen Pharmaceuticals, INC | $142.90 | 2019-2020 | |
| Amneal Pharmaceuticals LLC | $131.82 | 2019-2025 | Unithroid |
| Horizon Therapeutics Plc | $131.02 | 2021-2022 | |
| Ascendis Pharma Endocrinology INC | $124.99 | 2023 | |
| Eisai INC. | $91.89 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $71.66 | 2019 | |
| Antares Pharma, INC. | $63.96 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $61.61 | 2019-2020 | |
| Esperion Therapeutics, INC. | $47.59 | 2020-2021 | |
| Dexcom, INC. | $41.83 | 2023 | Dexcom G6 Transmitter |
| Ibsa Pharma INC. | $39.16 | 2019-2020 | |
| Becton, Dickinson and Company | $39.10 | 2019-2021 | |
| Companion Medical, INC. | $32.64 | 2020 | |
| Ultragenyx Pharmaceutical INC. | $21.94 | 2021 | |
| Shire North American Group INC | $18.79 | 2019 | |
| Vivus LLC | $18.38 | 2019 | |
| Senseonics, Incorporated | $14.00 | 2020 | |
| Recordati_rare_diseases_inc. | $12.94 | 2020 | |
| Pfizer INC. | $10.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monica Munoz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.